{"id":"W2118982164","doi":"10.1056/nejmoa1305133","title":"Safety and Tumor Responses with Lambrolizumab (Anti–PD-1) in Melanoma","year":2013,"lang":"en","type":"article","venue":"New England Journal of Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":3395,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute","keywords":"Medicine; Ipilimumab; Rash; Adverse effect; Melanoma; Internal medicine; Response Evaluation Criteria in Solid Tumors; Gastroenterology; Cohort; Cancer; Confidence interval; Surgery; Immunotherapy; Chemotherapy; Phases of clinical research","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001282689,0.0001831721,0.0004447452,0.0001678541,0.0001129537,0.0002766697,0.0001971735,0.0003279071,0.0005659955],"category_scores_gemma":[0.001195198,0.000109567,0.0005242609,0.0001462808,0.0002198599,0.0002220625,0.0001272328,0.0008798392,0.0001343968],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004756523,"about_ca_system_score_gemma":0.0003050062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003486689,"about_ca_topic_score_gemma":0.0003883723,"domain_scores_codex":[0.9995494,0.0001923509,0.00003840193,0.00007219367,0.00009981298,0.00004770618],"domain_scores_gemma":[0.9990335,0.0002753848,0.0004077982,0.00005934597,0.00008142643,0.0001425997],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.149788,0.01053866,0.2683672,0.001186643,0.001442056,0.0009370212,0.0007073621,0.009731565,0.1597119,0.000278284,0.002628064,0.3946832],"study_design_scores_gemma":[0.01964003,0.4067774,0.5161633,0.0001640371,0.001009248,0.003232127,0.0001767728,0.006202263,0.03799253,0.0004009471,0.008203245,0.00003815845],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961445,0.002763895,0.0002647273,0.00009660212,0.00001685144,0.00006261202,0.0001063388,0.0000169863,0.0005273849],"genre_scores_gemma":[0.9991091,0.000403552,0.0001111023,0.00009369733,0.00002364476,0.00002132246,0.0001233196,0.000002767104,0.0001114977],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001282689,"threshold_uncertainty_score":0.006783605,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01063699293075173,"score_gpt":0.2538321199604192,"score_spread":0.2431951270296674,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}